Extended Therapy Helps Drug-Addi... ( Use of detoxification medications pro...)

Extended Therapy Helps Drug-Addicted Teens

Date:11/4/2008

Use of detoxification medications produces noticeable results, study says

TUESDAY, Nov. 4 (HealthDay News) -- Teens treated for addiction to heroin or prescription painkillers are less likely to continue using these drugs if they receive extended treatment with a combination of detoxification medications, rather than short-term drug therapy, a new study found.

Both buprenorphine and naloxone have been shown to be effective in treating opioid addiction, but only limited use of these drugs has been recommended for younger patients. Buprenorphine works by relieving withdrawal symptoms and naloxone prevents or reverses the effects of injected opioids.

"If you keep these young kids, average one-and-a-half years of addiction, on buprenorphine-naloxone they did a lot better," said lead study author Dr. George Woody, a professor at the University of Pennsylvania's Department of Psychiatry. "When you took them off the buprenorphine-naloxone, their opioid use went up."

Among the 15-to-21-year-olds in the study, 55 percent used heroin, 35 percent used prescription opioids such as Vicodin and Oxycontin, and 10 percent said they used both heroin and prescription painkillers, Woody said.

"Treatment programs for kids with a short addiction history have traditionally been reluctant to use the medications for anything other than short-term detoxification," Woody said. "With opioid-addicted kids you should reconsider that reluctance."

The findings are published in the Nov. 5 issue of the Journal of the American Medical Association.

For the study, Woody's team randomly assigned 152 young people to 12 weeks of treatment with buprenorphine and naloxone, or to two weeks of treatment with the same drug combination. Patients in both groups also received individual and group counseling.

The researchers found that patients receiving extended treatment had more urine tests that were positive fo
'/>"/>

0

GOOD

Page: 1 2 3
Related medicine news :

1. Flynn Pharma Acquires Rights From Pacira Pharmaceuticals to DepoDur(R), the Only Extended-Release Epidural Opioid for Post-Operative Pain, in Europe
2. Mylan Announces Settlement of Paroxetine Hydrochloride Extended-Release Tablets with GlaxoSmithKline
3. Beckman Coulter Signs Agreements With Amerinet, Inc.; Ten-Year Partnership Extended for Another Three Years
4. Stay Young with an Extended Warranty for Your Body
5. Home Dialysis Clinical Research Study is Underway - Focuses on At-Home Extended Duration Treatment
6. Nurses working extended shifts, are tired at work and sleep little likely to drive drowsy
7. Venlafaxine extended-release effective for patients with major depression
8. ImaRx Therapeutics Submits Urokinase Data to FDA Supporting Extended Expiration Dating
9. Ambien CR(R) (zolpidem tartrate extended-release) tablets CIV Improved Chronic Insomnia in Patients with Co-Morbid Generalized Anxiety Disorder
10. Extended work hours should factor into return to job after injury
11. FDA Approves Luvox(R) CR (Fluvoxamine Maleate) Extended-Release Capsules for the Treatment of Social Anxiety Disorder (SAD) and Obsessive Compulsive Disorder (OCD)

Post Your Comments:

Extended Therapy Helps Drug-Addi...( Use of detoxification medications pro...),Health